BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diedisheim M, Carcarino E, Vandiedonck C, Roussel R, Gautier JF, Venteclef N. Regulation of inflammation in diabetes: From genetics to epigenomics evidence. Mol Metab 2020;41:101041. [PMID: 32603690 DOI: 10.1016/j.molmet.2020.101041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Arroba AI, Aguilar-diosdado M. Special Issue “The Prevention, Treatment, and Complications of Diabetes Mellitus”. JCM 2022;11:5305. [DOI: 10.3390/jcm11185305] [Reference Citation Analysis]
2 Zajec A, Trebušak Podkrajšek K, Tesovnik T, Šket R, Čugalj Kern B, Jenko Bizjan B, Šmigoc Schweiger D, Battelino T, Kovač J. Pathogenesis of Type 1 Diabetes: Established Facts and New Insights. Genes 2022;13:706. [DOI: 10.3390/genes13040706] [Reference Citation Analysis]
3 Wonnacott A, Denby L, Coward RJM, Fraser DJ, Bowen T. MicroRNAs and their delivery in diabetic fibrosis. Adv Drug Deliv Rev 2022;182:114045. [PMID: 34767865 DOI: 10.1016/j.addr.2021.114045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rojas A, Lindner C, Schneider I, Gonzàlez I, Araya H, Morales E, Gómez M, Urdaneta N, Araya P, Morales MA. Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer. World J Gastrointest Oncol 2021;13:1997-2012. [PMID: 35070037 DOI: 10.4251/wjgo.v13.i12.1997] [Reference Citation Analysis]
5 Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab 2021;48:101306. [PMID: 34813929 DOI: 10.1016/j.diabet.2021.101306] [Reference Citation Analysis]
6 González-Moles MÁ, Ramos-García P. State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature. J Clin Med 2021;10:5383. [PMID: 34830663 DOI: 10.3390/jcm10225383] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Huang L, Hu X. Molecular Mechanisms and Functions of lncRNAs in the Inflammatory Reaction of Diabetes Mellitus. Int J Endocrinol 2021;2021:2550399. [PMID: 34712322 DOI: 10.1155/2021/2550399] [Reference Citation Analysis]
8 Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev 2021;35:307-28. [PMID: 33649162 DOI: 10.1101/gad.346312.120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
9 Rodríguez-Vera D, Vergara-Castañeda A, Lazcano-Orozco DK, Ramírez-Vélez G, Vivar-Sierra A, Araiza-Macías MJ, Hernández-Contreras JP, Naranjo-Navarro CR, Salazar JR, Loza-Mejía MA, Pinto-Almazán R. Inflammation Parameters Associated with Metabolic Disorders: Relationship Between Diet and Microbiota. Metab Syndr Relat Disord 2021. [PMID: 34402660 DOI: 10.1089/met.2021.0022] [Reference Citation Analysis]
10 Li Y, Long W, Gao M, Jiao F, Chen Z, Liu M, Yu L. TREM2 Regulates High Glucose-Induced Microglial Inflammation via the NLRP3 Signaling Pathway. Brain Sci 2021;11:896. [PMID: 34356130 DOI: 10.3390/brainsci11070896] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Li X, Ye Y, Wang B, Zhao S. miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells. Diabetes Metab Syndr Obes 2021;14:2515-24. [PMID: 34113143 DOI: 10.2147/DMSO.S304055] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]